Sensitivity analyses did not affect the associations of SGLT-2 inhibitors with reduced AKI events compared with the control groups, DPP-4inhibitors, and GLP-1 agonists (Appendix 9 in S1 Text). Here, GCG is linked to acute kidney injury.